Altasciences Announces Launch of New Brand and Website

LAVAL, Quebec–(BUSINESS WIRE)–lt;a href=”” target=”_blank”gt;#Altascienceslt;/agt;–Altasciences,
a mid-size CRO specializing in a flexible, innovative approach to
providing comprehensive early stage drug development, including
preclinical, clinical, bioanalysis, and research services, has unveiled
a new brand identity and website.
Altasciences’ companies, Preclinical Services in Seattle, Algorithme
Pharma, Vince & Associates Clinical Research, and Algorithme Pharma USA,
are now further united under the Altasciences brand.

Feedback from our clients and third parties made it clear that our
current brand identity did not fully convey the company’s personable and
flexible approach, capabilities, expertise and, in particular, the
efforts put in to integrating their capabilities and sites with the goal
of providing a coordinated approach to early phase development. As a
result, Altasciences has aligned its brand with who they are and what
they do: Moving in Unison to deliver big impact with a personal touch.

We’re excited that our new messaging communicates how Altasciences
is uniquely positioned to closely partner with sponsors in early drug
development and provide the exceptional service our clients have come to
” said Julie-Ann
, Vice President of Marketing and Commercial Integration at
Altasciences. “The intention of our brand is to reflect the everyday
scientific heroes that make drug development a reality. It is about
highlighting the importance of partnering with our clients, as well as
the human aspect of drug development.

The brand logo, which has green ribbons moving together in a peak to
form an ‘A’, symbolizes the company’s dedication to working together to
maintain the highest scientific and operational standards necessary to
meet clients’ challenges, while always seeking new opportunities to
innovate. Green represents the color of life, growth, harmony, and
success. A refreshed graphic approach features imagery that represents
real-life moments, demonstrating the vibrancy of life and the essence of
what Altasciences does — supporting research that helps bring new
medicines to the people who need them, faster. The new identity has been
fully rolled out in a revamped company

We’ve spent the past 25 years partnering with our clients to
research and develop potentially life-saving therapeutics,
” said Chris
, CEO, Altasciences. “Now, our brand identity pays homage
to the strength of that heritage. It not only shows who we are as a
company, but where we are going.

About Altasciences

Altasciences is
a forward-thinking, mid-size contract research organization
offering pharmaceutical and biotechnology companies of all sizes a
proven, flexible approach to preclinical and early phase clinical
studies, from lead candidate selection to proof of concept. For over 25
years, Altasciences has been integrating into clients’ projects to help
support educated, faster, and more complete early drug development
decisions. Altasciences’ full-service solutions include preclinical
safety testing, clinical pharmacology, bioanalysis, program management,
medical writing, biostatistics, and data management, all of which can be
tailored to specific sponsor requirements. Altasciences… helping
sponsors get better drugs to the people who need them, faster.


Julie-Ann Cabana
913 304-4505